Marie Nougier

IDPC Secretariat

Marie Nougier

Head of Research and Communications

Since 2008, Marie Nougier has been responsible for the communications and publications work stream of IDPC, and also engages in networking, civil society capacity building activities, and policy advocacy engagement, in particular at the Commission on Narcotic Drugs. Marie is also supporting IDPC’s activities in Latin America, where she helps coordinate a project to reduce the incarceration rate of women for drug offences. Marie is also a member of the Core Group of the EU Civil Society Forum on Drugs. Her language skills in English, French, Spanish and Portuguese have constituted a valuable asset for the development of a multilingual centre of expertise at IDPC. Marie has a Masters’ Degree in international law, human rights and the law of armed conflicts. Before working at IDPC, she worked on issues related to compulsory drug detention in South East Asia at the World Health Organisation, as well as immigration, racism and police brutality in Western Europe at Amnesty International.

Translations

Related Content

CND 67: Key issues and opportunities

CND 67: Key issues and opportunities

Online
27 February 2024
The webinar will discuss key issues likely to structure the debates and draft resolutions, and present how IDPC network members have used this forum for their advocacy.
CND 65: Key issues and opportunities

CND 65: Key issues and opportunities

Online
1 March 2022
The webinar will shed light on the key issues that are likely to structure the debates, discuss tabled resolutions and opportunities for engagement (especially considering this year's hybrid format), and showcase the experience of IDPC network members in navigating and leveraging this forum for political advocacy.
7 November 2021
The Global Drug Policy Index 2021 - Analytical report

The Global Drug Policy Index 2021 - Analytical report

The Harm Reduction Consortium presents the first edition of the Global Drug Policy Index, which documents, measures and compares national-level drug policies against the UN Common Position on drugs.